103175-61-7

Basic information

• Product Name: 2-bromo-1-(2,4-dichlorophenyl)propan-1-one
• Synonyms: 2-Bromo-1-(2,4-dichlorophenyl)propane-1-one
• CAS NO: 103175-61-7
• Molecular Formula: C₉H₇BrCl₂O
• Molecular Weight: 282
• EINECS: 1533716-785-6
• Mol File: 103175-61-7.mol
• Article Data: 8

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2-bromo-1-(2,4-dichlorophenyl)propan-1-one(CAS DataBase Reference)
• NIST Chemistry Reference: 2-bromo-1-(2,4-dichlorophenyl)propan-1-one(103175-61-7)
• EPA Substance Registry System: 2-bromo-1-(2,4-dichlorophenyl)propan-1-one(103175-61-7)

Safety Data

• Hazardous Substances Data: 103175-61-7(Hazardous Substances Data)

Upstream product

• 6574-98-7 2,4-dichlorobenzylnitrile 
• 37885-41-9 2',4'-dichloropropiophenone 

Downstream Products

• 1321959-65-2 4-(2,4-dichlorophenyl)-5-methyl-N-(naphthalen-1-yl)thiazol-2-amine 
• 1321959-77-6 N₁-(4-(2,4-dichlorophenyl)-5-methylthiazol-2-yl)benzene-1,4-diamine 
• 1609483-25-1 ethyl 5-(2,4-dichlorophenyl)-1-(4-(2,4-dichlorophenyl)-5-methylthiazol-2-yl)-4-methyl-1H-pyrazole-3-carboxylate 
• 1609483-23-9 ethyl 5-(4-chlorophenyl)-1-(4-(2,4-dichlorophenyl)-5-methylthiazol-2-yl)-4-methyl-1H-pyrazole-3-carboxylate 
• 1609483-14-8 ethyl 1-(4-(2,4-dichlorophenyl)-5-methylthiazol-2-yl)-5-phenyl-1H-pyrazole-3-carboxylate 
• 1207259-62-8 5-[2-(2,4-dichloro-phenyl)-1-methyl-2-oxo-ethoxy]-3-ethyl-1H-pyrazole-4-carboxylic acid ethyl ester 
• 1207259-37-7 1-(2,4-dichloro-phenyl)-2-(5-ethyl-2H-pyrazol-3-yloxy)-propan-1-one 
• 1207259-14-0 1-(2,4-dichlorophenyl)-2-(4-(3,5-dimethyl-1H-1,2,4-triazol-1-yl)-3-methyl-1H-pyrazol-5-yloxy)propan-1-one 
• 1207259-13-9 1-(2,4-Dichloro-phenyl)-2-(5'-methyl-3-trifluoromethyl-2'H-[1,4']bipyrazolyl-3'-yloxy)-propan-1-one 
• 765278-98-6 2-phenyl-4-(2,4-dichlorophenyl)-5-methylimidazole 
• 502159-70-8 4-(2,4-dichloro-phenyl)-2-[1-(2,4-dichloro-phenyl)-cyclopropyl]-5-methyl-1H-imidazole 

Relevant articles and documents

Synthesis of three imidazole derivatives and corrosion inhibition performance for copper

Three imidazole derivatives, including 3-(4-(2,4-dichlorophenyl)-5-methyl-1H-imidazol-2-yl)pyridine (PDI), 2-(4-(2,4-dichlorophenyl)-5-methyl-1H-imidazol-2-yl)pyrazine (PAI) and 2-(4-(2,4-dichlorophenyl)-5-methyl-1H-imidazol-2-yl)pyrimidine (PMI), were synthesized. The structure of these compounds was confirmed by LC-MS, 1H NMR, 13C NMR and FTIR spectra. The inhibition performance in 3.5 wt% NaCl was investigated by electrochemical measurement and surface analysis. Results show that the corrosion efficiency of PDI (95.93%) was higher than PAI (69.61%) and PMI (20.46%), which is consistent with the adsorption energy calculated by molecular dynamics simulation. The corrosion inhibition mechanism could be explained by the metal–organic polymer film formed on the copper surface: on the one hand, the π-system formed by aromatic rings is tightly adsorbed on the copper substrates; on the other hand, the nitrogen atoms in the imidazole ring are coordinated with the metal ions in solution to form metal–organic polymer which could improve the compactness of the hydrophobic film.

1,2,3-triazole structure containing enol ether compounds as antifungal agent

The invention discloses 1,2,3-triazole structure containing enol ether compounds shown in a formula (I) or pharmaceutically acceptable salts, solvates, optical isomers or polymorphic substances thereof. X is N or CH; R1 and R2 are H atoms, halogen, nitro, cyano, C1-C6 alkyl and halogenated C1-C6 alkyl, and R1 and R2 can be the same or different; R3 and R4 are H atoms, halogen, hydroxyl, an amino group, a cyano group, nitro, halogenated C1-C6 alkyl, C1-C6 alkyl, C6-C10 aryl, C4-C6 aromatic heterocyclic groups, C1-C6 alkoxy and halogenated C1-C6 alkoxy; R3 and R4 can be the same or different. Asthe antifungal agent, the 1,2,3-triazole structure containing enol ether compounds have higher killing effects on clinically common pathogenic fungi and are expected to overcome the defects of largetoxic and side effects, high drug resistance probability and the like of azole antifungal drugs widely used clinically at present.

Organic compounds

There are described pyrazolo[5.1-b]oxazole derivatives useful as corticotropin releasing factor (CRF1) receptor antagonists.